{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:53:37Z","timestamp":1787237617334,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smedj"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>INTRODUCTION Large-volume paracentesis (LVP) is the first-line treatment for decompensated cirrhosis with refractory ascites. While ascitic drain removal (ADR) within 72 hours of the procedure was once considered safe, it was uncertain whether ADR within 24 hours could further reduce the risk of ascitic drain-related bacterial peritonitis (AdBP). This study aimed to investigate the association between the timing of ADR and the presence of AdBP.  METHODS All patients with cirrhosis with refractory ascites who underwent LVP in our institution from 2014 to 2017 were studied. AdBP was diagnosed based on an ascitic fluid neutrophil count \u2265 250 cells\/mm3 or positive ascitic fluid culture following recent paracentesis within two weeks.  RESULTS A total of 131 patients who underwent LVP were followed up for 1,806 patient-months. Their mean age was 68.3 \u00b1 11.6 years, and 65.6% were male. Their mean Model for End-Stage Liver Disease score was 15.2. The overall incidence of AdBP was 5.3%. ADR beyond 24 hours was significantly associated with a longer median length of stay (five days vs. three days, p &lt; 0.001), higher risk of AdBP (0% vs. 8.9%, p = 0.042) and acute kidney injury (AKI) following LVP (odds ratio 20.0, 95% confidence interval 2.4\u2013164.2, p = 0.021). The overall survival was similar in patients who underwent ADR within and beyond 24 hours of LVP.  CONCLUSION ADR within 24 hours of LVP is associated with a reduced risk of AdBP and AKI. As AdBP is associated with resistant organisms and AKI, we recommend prompt ADR within 24 hours, especially in patients who have Child-Pugh class C alcoholic cirrhosis.<\/jats:p>","DOI":"10.11622\/smedj.2021049","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T23:42:11Z","timestamp":1618789331000},"page":"659-664","source":"Crossref","is-referenced-by-count":4,"title":["Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites"],"prefix":"10.4103","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0727-1183","authenticated-orcid":false,"given":"YJ","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HM","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PT","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EK","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JY","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PH","family":"Thurairajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","article-title":"Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema","volume":"57","author":"Sol\u00e0","year":"2012","unstructured":"1. Sol\u00e0 E, Watson H, Graupera I, et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol 2012; 57:1199-206.","journal-title":"J Hepatol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69:406-60.","DOI":"10.1016\/j.jhep.2018.08.009"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","unstructured":"3. Runyon BA; AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology 2013; 57:1651-3.","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/0016-5085(87)91007-9","article-title":"Results of a randomized study","volume":"93","author":"Gin\u00e9s","year":"1987","unstructured":"4. Gin\u00e9s P, Arroyo V, Quintero E, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987; 93:234-41.","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites","volume":"37","author":"Sola-Vera","year":"2003","unstructured":"5. Sola-Vera J, Mi\u00f1ana J, Ricart E, et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003; 37:1147-53.","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gin\u00e8s","year":"1996","unstructured":"6. Gin\u00e8s A, Fern\u00e1ndez-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111:1002-10.","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5114\/ceh.2019.83157","article-title":"Paracentesis-induced acute kidney injury in decompensated cirrhosis - prevalence and predictors","volume":"5","author":"Patil","year":"2019","unstructured":"7. Patil V, Jain M, Venkataraman J. Paracentesis-induced acute kidney injury in decompensated cirrhosis - prevalence and predictors. Clin Exp Hepatol 2019; 5:55-9.","journal-title":"Clin Exp Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","unstructured":"8. Gin\u00e8s P, Tit\u00f3 L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94:1493-502.","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1478-3231.2008.01734.x","article-title":"A randomized pilot study","volume":"28","author":"Appenrodt","year":"2008","unstructured":"9. Appenrodt B, Wolf A, Gr\u00fcnhage F, et al. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. Liver Int 2008; 28:1019-25.","journal-title":"Liver Int"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00042737-200403000-00008","article-title":"Understanding the mechanisms of paracentesis-induced circulatory dysfunction","volume":"16","author":"Sola-Vera J","year":"2004","unstructured":"10. Sola-Vera J, Such J. Understanding the mechanisms of paracentesis-induced circulatory dysfunction. Eur J Gastroenterol Hepatol 2004; 16:295-8.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/jgh.13709","article-title":"Urgency to treat patients with chronic hepatitis C in Asia","volume":"32","author":"Kao","year":"2017","unstructured":"11. Kao JH, Ahn SH, Chien RN, et al. Urgency to treat patients with chronic hepatitis C in Asia. J Gastroenterol Hepatol 2017; 32:966-74.","journal-title":"J Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00042737-200403000-00016","article-title":"Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction","volume":"16","author":"Coll","year":"2004","unstructured":"12. Coll S, Vila MC, Molina L, et al. Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction. Eur J Gastroenterol Hepatol 2004; 16:347-53.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1007\/s10620-016-4140-3","article-title":"Albumin may prevent the morbidity of paracentesisinduced circulatory dysfunction in cirrhosis and refractory ascites: a pilot study","volume":"61","author":"Tan","year":"2016","unstructured":"13. Tan HK, James PD, Wong F. Albumin may prevent the morbidity of paracentesisinduced circulatory dysfunction in cirrhosis and refractory ascites: a pilot study. Dig Dis Sci 2016; 61:3084-92.","journal-title":"Dig Dis Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/imj.12843","article-title":"Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites","volume":"45","author":"Kathpalia","year":"2015","unstructured":"14. Kathpalia P, Bhatia A, Robertazzi S, et al. Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites. Intern Med J 2015; 45:1026-31.","journal-title":"Intern Med J"},{"key":"ref14","unstructured":"15. Nadir A, Van Thiel DH. Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter. J Ayub Med Coll Abbottabad 2010; 22:37-41."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/hep.20317","article-title":"Performance standards for therapeutic abdominal paracentesis","volume":"40","author":"Grabau","year":"2004","unstructured":"16. Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology 2004; 40:484-8.","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol 2018; 69:154-81.","DOI":"10.1016\/j.jhep.2018.03.018"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1007\/s10620-011-1792-x","article-title":"Continuous peritoneal drainage of large-volume ascites","volume":"56","author":"Van Thiel","year":"2011","unstructured":"18. Van Thiel DH, Moore CM, Garcia M, George M, Nadir A. Continuous peritoneal drainage of large-volume ascites. Dig Dis Sci 2011; 56:2723-7.","journal-title":"Dig Dis Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.11622\/smedj.2019085","article-title":"Short- and long-term predictors of spontaneous bacterial peritonitis in Singapore","volume":"61","author":"Wong","year":"2020","unstructured":"19. Wong YJ, Kalki RC, Lin KW, et al. Short- and long-term predictors of spontaneous bacterial peritonitis in Singapore. Singapore Med J 2020; 61:419-25.","journal-title":"Singapore Med J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/hep.30494","article-title":"Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis","volume":"69","author":"Mahmud","year":"2019","unstructured":"20. Mahmud N, Kaplan DE, Taddei TH, Goldberg DS. Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis. Hepatology 2019; 69:2150-63.","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/0016-5085(93)90284-J","article-title":"Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites","volume":"104","author":"Andreu","year":"1993","unstructured":"21. Andreu M, Sola R, Sitges-Serra A, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993; 104:1133-8.","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Lata J, Fejfar T, Krechler T, et al. Spontaneous bacterial peritonitis in the Czech Republic: prevalence and aetiology. Eur J Gastroenterol Hepatol 2003; 15:739-43.","DOI":"10.1097\/01.meg.0000059160.46867.62"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","article-title":"Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease","volume":"32","author":"Parlesak","year":"2000","unstructured":"23. Parlesak A, Sch\u00e4fer C, Sch\u00fctz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000; 32:742-7.","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","article-title":"Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis","volume":"48","author":"Stadlbauer","year":"2008","unstructured":"24. Stadlbauer V, Mookerjee RP, Hodges S, et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol 2008; 48:945-51.","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/BF02282340","article-title":"Small bowel bacterial overgrowth in patients with alcoholic cirrhosis","volume":"41","author":"Casafont Morencos","year":"1996","unstructured":"25. Casafont Morencos F, de las Heras Casta\u00f1o G, Mart\u00edn Ramos L, et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1996; 41:552-6.","journal-title":"Dig Dis Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0168-8278(01)00228-8","article-title":"Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing","volume":"36","author":"Veldt","year":"2002","unstructured":"26. Veldt BJ, Lain\u00e9 F, Guillygomarc'h A, et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. J Hepatol 2002; 36:93-8.","journal-title":"J Hepatol"}],"container-title":["Singapore Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.smj.org.sg\/article\/clinical-implications-prompt-ascitic-drain-removal-cirrhosis-refractory-ascites","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T06:53:14Z","timestamp":1660027994000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.smj.org.sg\/article\/clinical-implications-prompt-ascitic-drain-removal-cirrhosis-refractory-ascites"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]},"published-print":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.11622\/smedj.2021049","relation":{},"ISSN":["0037-5675","2737-5935"],"issn-type":[{"value":"0037-5675","type":"print"},{"value":"2737-5935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}